Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise L Cecil

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Immunology|September 16, 2021
Multi-Epitope-Based Vaccines for Colon Cancer Treatment and PreventionLauren R Corulli, Denise L Cecil, Ekram Gad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2017
Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells <i>In Vivo</i>Denise L Cecil, Meredith Slota, Megan M O'Meara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
The pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuliDenise L Cecil, C Thomas G Appleton, Monika D Polewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune ResponsesDenise L Cecil, John B Liao, Yushe Dang, et al.
Molecular Cancer Therapeutics|March 14, 2020
Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary CancersMary L Disis, Lauren R Corulli, Ekram A Gad, et al.
Scientific Reports|August 10, 2022
Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancerDenise L Cecil, Benjamin Curtis, Ekram Gad, et al.
Journal for Immunotherapy of Cancer|May 21, 2015
Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancerJohn B Liao, Kelsie J Ovenell, Erin E M Curtis, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2013
A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast diseaseMary L Disis, Ekram Gad, Daniel R Herendeen, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancerSasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Immunology|September 16, 2021
Multi-Epitope-Based Vaccines for Colon Cancer Treatment and PreventionLauren R Corulli, Denise L Cecil, Ekram Gad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2017
Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells <i>In Vivo</i>Denise L Cecil, Meredith Slota, Megan M O'Meara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
The pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuliDenise L Cecil, C Thomas G Appleton, Monika D Polewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune ResponsesDenise L Cecil, John B Liao, Yushe Dang, et al.
Molecular Cancer Therapeutics|March 14, 2020
Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary CancersMary L Disis, Lauren R Corulli, Ekram A Gad, et al.
Scientific Reports|August 10, 2022
Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancerDenise L Cecil, Benjamin Curtis, Ekram Gad, et al.
Journal for Immunotherapy of Cancer|May 21, 2015
Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancerJohn B Liao, Kelsie J Ovenell, Erin E M Curtis, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2013
A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast diseaseMary L Disis, Ekram Gad, Daniel R Herendeen, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancerSasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
Pageof 2